[Trastuzumab as adjuvant treatment of early breast cancer after surgical treatment]
Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)
Record ID 32013000059
Danish
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
http://www.sst.dk/publ/Publ2006/CEMTV/Laegemidler/Herceptin.pdf
URL for additional information:
http://www.sst.dk/English/DACEHTA/Publications_alphabetical_order/Trastuzumab%20as%20adjuvant%20treatment%20of%20early%20breast%20cancer%20after%20surgical%20treatment.aspx
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Denmark
MeSH Terms
- Antineoplastic Agents
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
Contact
Organisation Name:
Danish Centre for Evaluation and Health Technology Assessment
Contact Address:
National Board of Health, PO Box 1881, Islands Brygge 67, DK-2300 Copenhagen S, Denmark. Tel: 45 72 22 74 48; Fax: 45 72 22 74 07/67
Contact Name:
dacehta@sst.dk
Contact Email:
dacehta@sst.dk
Copyright:
Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.